-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.P1.47 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 11, 2021: 5:30 PM-7:30 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Massimo Breccia, MD1*, Elisabetta Abruzzese, MD2, Fabio Stagno, MD, PhD3, Alessandra Iurlo, MD, PhD4*, Fabrizio Pane, MD5, Immacolata Attolico, MD6*, Paolo Sportoletti, MD7*, Patrizia Pregno8*, Sara Galimberti9*, Barbara Scappini10*, Roberto M. Lemoli, MD11,12, Sergio Siragusa, Prof, MD13, Isabella Capodanno, MD14*, Francesca Chiodi, MD15*, Giuseppe Nicola Saglio, MD, PhD16 and Gianantonio Rosti, MD17*

1Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
2Department of Hematology S. Eugenio Hospital, Tor Vergata University, Rome, Italy, Roma, Italy
3Hematology Unit, AOU Policlinico “Rodolico – San Marco” Rodolico Hospital, Catania, Catania, Italy
4Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
6Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy
7Institute of Hematology and Center of Hemato-Oncology Research (CREO), University of Perugia, Perugia, Italy
8Hematology Unit, Az Ospedaliero Universitaria Città' della Salute e della Scienza, Turin, Italy
9Department of Clinical and Experimental Medicine, Hematology section, University of Pisa, Pisa, Italy
10Hematology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy
11Department of Medicine (DiMI), University of Genoa, Genova, Italy
12IRCCS Policlinico San Martino, Genoa, Italy
13Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PRO.MI.SE), University of Palermo, Palermo, Italy
14Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
15Novartis Farma S.p.A., Origgio, Italy
16Hematology, University of Turin, Turin, Italy
17IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy

Carlo Gambacorti-Passerini, MD1, Tim H Brümmendorf, MD2, Elisabetta Abruzzese, MD3, Kevin R. Kelly, MD, PhD4*, Vivian G. Oehler, MD5, Valentín Garcia-Gutiérrez, MD, PhD6, Henrik Hjorth-Hansen, MD7, Thomas Ernst, MD8, Eric Leip, PhD9*, Simon Purcell, MPharm10*, Gerald Luscan11*, Andrea Viqueira12*, Frank Giles, MD13* and Andreas Hochhaus, MD14

1University of Milan-Bicocca, Monza, Italy
2Universitätsklinikum RWTH Aachen, Aachen, Germany
3Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
4Keck School of Medicine of USC, Los Angeles, CA
5Fred Hutchinson Cancer Research Ctr., Seattle, WA
6Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
7Department of Hematology, St. Olavs University Hospital, Trondheim, Norway
8Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany
9Pfizer Inc., Cambridge, MA
10Pfizer Ltd, London, GBR
11Pfizer PIO, Paris, France
12Pfizer SLU, Madrid, Spain
13Developmental Therapeutics Consortium, Chicago, IL
14Department of Internal Medicine II, Jena University Hospital, Jena, Germany

Sarit Assouline, MD, MSc1,2, Maria Cristina Miggiano, MD3*, Elisabetta Abruzzese, MD4, Chiara Elena, MD5*, Giovanni Caocci, MD6*, Susanne Saussele, MD 7, Francesca Lunghi, MD8*, Alberto Alvarez-Larran9*, Barbara Mora, MD10*, Sigi Petrela, MD11*, Laura Antolini, PhD12*, Carlo Gambacorti-Passerini, MD13 and Alessandra Iurlo, MD, PhD14*

1Department of Medicine and Oncology, McGill University/Jewish General Hospital, Montreal, QC, Canada
2Groupe Québécois de Recherche en LMC-NMP/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group (GQR LMC-NMP), Montreal, QC, Canada
3Hematology Department, San Bortolo Hospital, Vicenza, Italy
4Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
5Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
6Department of Medical Sciences, University of Cagliari, Cagliari, Italy
7Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany
8Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, Milano, Italy
9Servicio de Hematologia, Hospital Clinic de Barcelona - GEMFIN, Barcelona, Spain
10Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, University of Insubria, Varese, Italy
11University of Milano-Bicocca, Monza, Italy
12Dept of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
13Hematology, University of Milano-Bicocca, San Gerardo Hospital, Monza, Italy
14Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Chikashi Yoshida, MD, PhD1, Hiroki Yamaguchi, MD, PhD2*, Noriko Doki3*, Kazunori Murai, MD, PhD4, Masaki Iino, MD, PhD5*, Yoshihiro Hatta, MD, PhD6, Makoto Onizuka, MD, PhD7, Norio Yokose, MD, PhD8*, Katsumichi Fujimaki, MD, PhD9*, Masao Hagihara, MD10*, Gaku Oshikawa, MD, PhD11*, Kayoko Murayama, MD, PhD12*, Takashi Kumagai, MD, PhD13, Shinya Kimura, MD, PhD14*, Hideharu Muto, MD, PhD15*, Kensuke Usuki, MD, PhD16, Kenji Yokoyama, MD, PhD17, Koh Yamamoto, MD, PhD18*, Nobuyuki Aotsuka, MD, PhD19*, Kenichi Ishizawa, MD, PhD20*, Naoki Takezako, MD, PhD21, Takuto Miyagishima, MD, PhD22*, Tadao Ishida, MD, PhD23, Atsushi Shinagawa, MD, PhD24*, Kentaro Wakasa, MD25*, Tsuyoshi Nakamaki, MD, PhD26, Naoto Tomita, MD, PhD27, Katsutoshi Ozaki, MD, PhD28, Takayoshi Itoh, MD29*, Shugo Kowata, MD, PhD.30*, Kenji Tajika, MD31*, Takayuki Fujio, MD32*, Masahiro Onozawa, MD, PhD33, Masahide Yamamoto, MD, PhD34*, Takeshi Kondo, MD, PhD35, Yuho Najima3, Noriyoshi Iriyama, MD, PhD6*, Ikuyo Tsutsumi, MD, MPH, PhD1*, Koji Oba, PhD36*, Hiroshi Kojima, MD, PhD37*, Hisashi Sakamaki, MD, PhD3* and Koiti Inokuchi, MD, PhD, Prof.2*

1Department of Hematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan
2Department of Hematology, Nippon Medical School, Tokyo, Japan
3Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
4Department of Hematology, Iwate Prefectural Central Hospital, Morioka, Japan
5Department of Medical Oncology, Yamanashi Prefectural Central Hospital, Kofu, Japan
6Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
7Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
8Department of Hematology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan
9Department of Hematology, Fujisawa City Hospital, Fujisawa, Japan
10Department of Hematology, EIJU GENERAL HOSPITAL, Taito-Ku, Japan
11Japanese Red Cross Musashino Hospital, Musashino, Japan
12Division of Hematology, Gunma Prefectural Cancer Center, Ohta, Japan
13Department of Hematology, Ohme Municipal General Hosp., Oume-Shi, TKY, Japan
14Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga-city, Japan
15Division of hematology, Tokyo Metropolitan Otsuka Hospital, Tokyo, Japan
16Department of Hematology, NTT Medical Center, Tokyo, Japan
17Tokai University Hachioji Hospital, Tokyo, Japan
18Department of Hematology, Yokohama City Minato Red Cross Hospital, Kanagawa, Japan
19Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan
20Yamagata University Hospital, Yamagata, Japan
21Department of Hematology, Disaster Medical Center of Japan, Tachikawa, Japan
22Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
23Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
24Department of Hematology, Hitachi General Hospital, Ibaraki, Japan
25Obihiro-Kosei General Hospital, Obihiro, Japan
26Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
27St.Marianna University School of Medicine, Kawasaki, Japan
28NIPPON MEDICAL SCHOOL TAMANAGAYAMA HOSPITAL, Tama, Japan
29JA Toride Medical Center, Toride, Japan
30Iwate Medical University School of Medicine, Yahaba, Japan
31Yokohamaminami-Kyousai Hospital, Yokohama, Japan
32Department of Hematology, Ibaraki Prefectural Central Hospital, Ibaraki, Japan
33Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
34Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
35Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
36Department of Biostatistics, The University of Tokyo, Tokyo, Japan
37Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital, Kasama, Japan

Jorge E. Cortes, MD1, Andreas Hochhaus, MD2, Naoto Takahashi, MD, PhD3, Richard A. Larson, MD4, Ghayas C. Issa, MD5, Felice Bombaci6*, Nicholas Ramscar, MBBS7*, Shruti Kapoor8*, Sophie Ifrah9* and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA10

1Georgia Cancer Center Augusta University, Augusta, GA
2Department of Internal Medicine II, Jena University Hospital, Jena, Germany
3Akita University School of Medicine, Akita, Japan
4Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6CML Advocates Network, Turnin, Italy
7Novartis Pharma AG, Basel, Switzerland
8Novartis Pharmaceuticals Corporation, East Hanover, NJ
9Novartis Pharma SAS, Rueil-Malmaison, France
10South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, SA, Australia

Anna Sicuranza, PhD1*, Ilaria Ferrigno, PhD1*, Elisabetta Abruzzese, MD2, Alessandra Iurlo, MD, PhD3*, Sara Galimberti4*, Antonella Gozzini, MD5*, Luigiana Luciano, MD6, Fabio Stagno, MD, PhD7, Antonella Russo Rossi8*, Nicola Sgherza, MD9*, Daniele Cattaneo10*, Corrado Zuanelli Brambilla, MD1*, Cristina Marzano1*, Carmen Fava, M.D.11, Olga Mulas12*, Emanuele Cencini, MD13*, Alessandro Gozzetti14*, Luca Puccetti15* and Monica Bocchia15*

1Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy
2Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy
3Hematology Division, Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy
4Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
5Hematology, AOU Careggi, University of Firenze, Florence, Italy
6Hematology Unit, Federico II University of Naples, Napoli, Italy
7Hematology Unit, AOU Policlinico “Rodolico – San Marco” Rodolico Hospital, Catania, Catania, Italy
8Hematology, University of Bari, Bari, Italy
9Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy, Bari, ITA
10FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILANO, ITA
11Hematology Division, Ospedale Mauriziano, University of Turin, Torino, Italy
12Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
13Division of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy
14Hematology Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy
15Hematology, Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy

Fadi Haddad, MD1*, Hagop Kantarjian, MD1, Elias Joseph Jabbour, MD2, Ghayas C. Issa, MD1, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MB Bs3, Marina Konopleva, MD, PhD1, Alessandra Ferrajoli, MD1, Tapan M. Kadia, MD4, Naveen Pemmaraju, MD1, Koichi Takahashi, MD, PhD5, Yesid Alvarado, MD1, Musa Yilmaz, MD6, Gautam Borthakur, MD7, Courtney D. DiNardo, MD, MSCE1, Nitin Jain, MD6, Naval Daver, MD8, Nicholas Short, MD3, Sherry A. Pierce, BSN, BA1*, Jorge E. Cortes, MD9 and Koji Sasaki, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, MD Anderson Cancer Center, Houston, TX
7MD Anderson Cancer Center, The University of Texas, Houston, TX
8MD Anderson Cancer Center, Houston, TX
9Georgia Cancer Center Augusta University, Augusta, GA

Yueksel Filik1,2*, Karin Bauer, Dr.2,3*, Barbara Peter, DVM2,3*, Emir Hadzijusufovic, DVM2,3,4*, Georg Greiner, MD3,5,6*, Nadine Witzeneder, MSc3,5*, Gregor Hoermann, MD3,7, Karoline V. Gleixner, MD2,3*, Wolfgang R. Sperr, MD2,3* and Peter Valent, MD2,3

1Ludwig Boltzmann Institute for Hematology and Oncology, Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medi, Vienna, Austria
2Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
3Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria
4Department for Companion Animals and Horses, University Clinic for Small Animals, Internal Medicine Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria
5Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
6Medical Diagnostic Laboratories, Ihr Labor, Vienna, Austria
7MLL Munich Leukemia Laboratory, Munich, Germany

Anna G. Turkina, Prof., MD1, Olga Vinogradova, MD2,3,4*, Elza Lomaia, MD, PhD5*, Evgeniya Shatokhina, MD, PhD6*, Oleg A. Shukhov, MD, PhD7*, Andrey Zaritskey5*, Ekaterina Yu. Chelysheva, MD, PhD8*, Dzhariyat Shikhbabaeva9*, Irina Nemchenko, MD, PhD10*, Anna Petrova, MD11*, Anastasiya Bykova, MD10*, Vasily Shuvaev, MD12,13, Nadia Siordia, MD14*, Jorge E. Cortes, MD15,16, Robert Peter Gale17, Michele Baccarani, MD18, Oliver Ottmann, MD, FRCPath19, Ilya Mikhailov20*, Fedor Novikov, PhD21*, Veronika Shulgina, PhD, MD21* and Ghermes Chilov, PhD22*

1National Research Center for Hematology, Moscow, Russia
2Hematology Center of Botkin Hospital, Moscow, Russian Federation
3Dmitry Rogachev National Research Center of Pediatric Hematology/Oncology and Immunology, Moscow, Russian Federation
4Pirogov Russian National Research Medical University, Moscow, Russian Federation
5Almazov National Medical Research Centre, St. Petersburg, Russian Federation
6Central State Medical Academy, Affairs of the President of Russian Federation, Moscow, Russian Federation
7National Research Center for Hematology, Russian Federation, Moscow, Russia
8Moscow, AZ
9Hematological Moscow City Center, Botkin City Clinical Hospital, Moscow, Russian Federation
10National Research Center for Hematology, Moscow, Russian Federation
11Moscow, Russia
12City Clinical Hospital n.a. V.V. Veresaev of the Moscow Department of Healthcare, Moscow, Russian Federation
13Federal State Budget Institution “Russian Scientific-Research Institute of Hematology and Transfusiology of Federal Medical-Biological Agency”, St. Petersburg, Russia
14Institute of Hematology, Almazov National Medical Research Centre, St. Petersburg, Russian Federation
15Georgia Cancer Center Augusta University, Augusta, GA
16Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
17Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
18Institute of Hematology "L. & A. Seràgnoli", St. Orsola University Hospital, Bologna, Italy
19Cardiff University, Cardiff, United Kingdom
20Fusion Pharma, Moscow, Russian Federation
21Fusion Pharma LLC, Moscow, Russian Federation
22Fusion Pharma, LLC, Moscow, Russia

Anna G. Turkina, Prof., MD1, Oleg A. Shukhov, MD, PhD1*, Elza Lomaia, MD, PhD2*, Elena V. Morozova3*, Anna Petrova, MD1*, Ekaterina Yu. Chelysheva, MD, PhD1*, Tamara Chitanava4*, Julia J. Vlasova5*, Irina Nemchenko, MD, PhD1*, Anastasiya Bykova, MD1*, Margarita Gurianova, MD1* and Andrey Zaritsky, MD4*

1National Research Center for Hematology, Moscow, Russian Federation
2Almazov National Medical Research Centre, St. Petersburg, Russian Federation
3RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
4Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation
5RM Gorbacheva Research Institute, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation

Akriti G Jain, MD1, Quinto J Gesiotto, MD2, Somedeb Ball, MD1, Lisa Nodzon, PhD, ARNP, AOCNP1*, Amanda Rodriguez, PA1*, Rami S. Komrokji, MD1, David A. Sallman, MD3, Eric Padron, MD1, Andrew T. Kuykendall, MD1, Onyee Chan, MD4, Jeffrey E. Lancet, MD5, Javier Pinilla Ibarz, MD, PhD1 and Kendra Sweet, MD1

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Medicine, University of South Florida, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Department of Malignant Hematology, H. Lee Moffitt Cancer Ctr. & Rsrch. Institute, Tampa, FL

Torsten Dahlen, MD1*, Camille Kockerols, MS2*, Germano Ferreira, PhD3*, Peter E. Westerweel, MD, PhD4*, Jiří Mayer, Prof, MD5, Tarek Sahmoud6*, David Wormser, PhD3*, Lillian Yau, PhD3* and Daniela Žácková, MD5*

1Karolinska University Hopsital, Sverige, Solna, Sweden
2Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
3Novartis Pharma AG, Basel, Switzerland
4Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
5Department of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
6Novartis Pharmaceuticals Corporation, East Hanover, NJ

Roberto Latagliata1*, Ida Carmosino, MD2*, Ambra Di Veroli, MD1*, Emilia Scalzulli, MD3*, Gioia Colafigli, MD4*, Maria Cristina Scamuffa, MD5*, Alessio Di Prima, MD5*, Cinzia De Gregoris, MD1*, Sara Pepe, MD4*, Marco Mancini, MD6*, Giulio Trapè, MD1*, Maurizio Martelli, MD2*, Robin Foa, MD2 and Massimo Breccia, MD2*

1Hematology, Belcolle Hospital, Viterbo, Italy
2Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
3Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy
4Department of Traslational and Precision Medicine - Hematology, University Sapienza, Rome, Italy
5Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy
6Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy

Mario Tiribelli, MD1*, Isabella Capodanno, MD2*, Maria Cristina Miggiano, MD3*, Cristina Bucelli, MD4*, Francesco Cavazzini, MD5*, Sabrina Leonetti Crescenzi, MD6*, Sabina Russo, MD7*, Emilia Scalzulli, MD8*, Andrea Bernardelli9*, Luigiana Luciano, MD10, Olga Mulas11*, Giuseppina Loglisci, MD12*, Chiara Elena, MD13*, Umberto Pizzano, MD14*, Immacolata Attolico, MD15*, Gianni Binotto, MD16*, Elena Crisà, MD17*, Paolo Sportoletti, MD18*, Ambra Di Veroli, MD19*, Anna Rita Scortechini, MD20*, Annapaola Leporace, MD21*, Maria Basile, MD22*, Monica Crugnola, MD23*, Fabio Stagno, MD, PhD24, Pamela Murgano, MD25*, Davide Rapezzi, MD26*, Alessandra Malato, MD, PhD27*, Michele Pizzuti, MD28*, Debora Luzi29*, Malgorzata Monika Trawinska, MD30*, Alessandra Iurlo, MD, PhD4*, Monica Bocchia31*, Carmen Fava, M.D.32, Giovanni Caocci, MD33, Massimiliano Bonifacio, MD34*, Giuseppe Nicola Saglio, MD, PhD35, Giorgina Specchia, MD36, Massimo Breccia, MD37* and Roberto Latagliata19*

1Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
2Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy
3Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
4Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy
6Hematology Unit, San Giovanni Hospital, Rome, Italy
7Division of Hematology, Policlinico “G. Martino”, University of Messina, Messina, Italy
8Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University, Rome, Italy
9Hematology, University of Verona, Verona, Italy
10Hematology Unit, Federico II University of Naples, Napoli, Italy
11Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
12Hematology Unit, Vito Fazzi Hospital, Lecce, Italy
13Department of Hematology Oncology, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
14Hematology, University of Udine, Udine, Italy
15Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy
16Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
17Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale Amedeo Avogadro, AOU Maggiore della Carità, Novara, Italy
18Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
19Hematology, Belcolle Hospital, Viterbo, Italy
20Division of Hematology, Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona, Ancona, Italy
21Hematology Unit, Azienda Ospedaliero Universitaria Sant' Andrea, Rome, Italy
22Hematology, Giuseppe Moscati Hospital, Taranto, Italy
23Hematology and BMT Center, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
24Chair and Hematology Section, Ferrarotto Hospital, Catania, Italy
25Division of Hematology, S. Elia Hospital, Caltanissetta, Italy
26S.C. Ematologia, ASO S. Croce e Carle, Cuneo, Italy
27Department of Hematology, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
28Ematologia, Azieda Ospedaliera S. Carlo, Potenza, Italy
29Hematology, Azienda Ospedaliera - S. Maria Terni, Terni, ITA
30Department of Hematology S. Eugenio Hospital, Rome, Italy
31Hematology, Hematology Unit, University of Siena, Azienda Ospedaliero Universitaria Senese, Siena, Italy
32Hematology Division, Ospedale Mauriziano, University of Turin, Torino, Italy
33Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
34Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
35Divisione Universitaria di Ematologia e Terapie Cellulari, A.O. Ordine Mauriziano, Turin, Italy
36Hematology Section, Department of Emergency and Transplantation - GIMEMA WP CML, University of Bari Aldo Moro, Bari, Italy
37Division of Hematology, Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy

Tamar Berger, MD1,2*, Adi Shacham Abulafia, MD1,2*, Shai Shimony, MD1,2*, Oren Pasvolsky, MD1,2*, Iuliana Vaxman, MD, BA1,2,3*, Yifat Miron, RN1*, Shimrit Feldman, RN1*, Avi Leader, MD1,2* and Pia Raanani, MD1,2

1Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Mayo Clinic Rochester, Division of Hematology, Rochester, MN

*signifies non-member of ASH